摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

[(2R,4aR,6R,7R,8S,8aR)-6-[[(2R,4aR,6R,7R,8S,8aR)-8-[(4-chlorophenyl)methoxy]-7-[(4-iodophenyl)methoxy]-2-phenyl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-2-phenyl-8-phenylmethoxy-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-7-yl] acetate | 1007886-04-5

中文名称
——
中文别名
——
英文名称
[(2R,4aR,6R,7R,8S,8aR)-6-[[(2R,4aR,6R,7R,8S,8aR)-8-[(4-chlorophenyl)methoxy]-7-[(4-iodophenyl)methoxy]-2-phenyl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-2-phenyl-8-phenylmethoxy-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-7-yl] acetate
英文别名
——
[(2R,4aR,6R,7R,8S,8aR)-6-[[(2R,4aR,6R,7R,8S,8aR)-8-[(4-chlorophenyl)methoxy]-7-[(4-iodophenyl)methoxy]-2-phenyl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-2-phenyl-8-phenylmethoxy-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-7-yl] acetate化学式
CAS
1007886-04-5
化学式
C49H48ClIO12
mdl
——
分子量
991.27
InChiKey
WKPOUKHVGKZNGG-AOXQTXQVSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    7.6
  • 重原子数:
    63
  • 可旋转键数:
    15
  • 环数:
    9.0
  • sp3杂化的碳原子比例:
    0.37
  • 拓扑面积:
    119
  • 氢给体数:
    0
  • 氢受体数:
    12

反应信息

  • 作为产物:
    描述:
    3-O-benzyl-4,6;4',6'-di-O-benzylidene-3'-O-(p-chlorobenzyl)-2'-O-(p-iodobenzyl)-α,α-D-trehalose乙酸酐4-二甲氨基吡啶 作用下, 以 吡啶 为溶剂, 以0.100 g的产率得到[(2R,4aR,6R,7R,8S,8aR)-6-[[(2R,4aR,6R,7R,8S,8aR)-8-[(4-chlorophenyl)methoxy]-7-[(4-iodophenyl)methoxy]-2-phenyl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-2-phenyl-8-phenylmethoxy-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-7-yl] acetate
    参考文献:
    名称:
    Synthetic Studies toward Mycobacterium tuberculosis Sulfolipid-I
    摘要:
    [GRAPHICS]Sulfolipid-I (SL-I) is an abundant metabolite found in the cell wall of Mycobacterium tuberculosis that is comprised of a trehalose 2-sulfate core modified with four fatty acyl substituents. The correlation of its abundance with the virulence of clinical isolates suggests a role for SL-I in pathogenesis, although its biological functions remain unknown. Here we describe the synthesis of a SL-I analogue bearing unnatural lipid substituents. A key feature of the synthesis was application of an intramolecular aglycon delivery reaction to join two differentially protected glucose monomers, one prepared with a novel alpha-selective glycosylation. The route developed for the model compound can be readily extended to the synthesis of native SL-I as well as additional analogues for use in the investigation of SL-I's functions.
    DOI:
    10.1021/jo702032c
点击查看最新优质反应信息